Technology Offerings

Novel Stroke Therapy Combines Glucocorticoids and Proteasome Inhibitors

ManyThe novel combination therapy, developed at the Julius-Maximilians-Universität Würzburg, is based on a combined treatment strategy using glucocorticoids

combined with inhibitors of the proteasome . The new therapy effectively and significantly reduced edema formation and moreover significantly ameliorated neurological performance in mouse models of stroke and brain trauma.

Further Information: PDF

Bayerische Patentallianz GmbH
Phone: +49 89 5480177-0

Contact
Peer Biskup

Comments (0)

Write a comment